Why the study?
To functionally characterize the novel L69P mutation identified in the hERG-PAS domain of a patient with clinically diagnosed LQTS.
Does the L69P mutation in the hERG channel cause trafficking deficiency and reduced potassium current?
Does the L69P mutation in the hERG channel cause trafficking deficiency and reduced potassium current?
The L69P mutation in the hERG PAS domain causes Long QT Syndrome through a dominant negative trafficking deficiency that reduces potassium current.
L69P may underlie LQTS via dominant-negative hERG trafficking defects; hypothesis-generating in animal models and leaves open human validation.
The congenital long QT syndrome (LQTS) is a cardiac disorder characterized by a prolonged QT interval on the electrocardiogram and an increased susceptibility to ventricular arrhythmias and sudden cardiac death. A frequent cause for LQTS is mutations in the KCNH2 gene (also known as the human ether-a-go-go-related gene or hERG), which reduce or modulate the potassium current IKr and hence alter cardiac repolarization. In a patient with a clinically diagnosed LQTS, we identified the mutation L69P in the N-terminal PAS (Per-Arnt-Sim) domain of hERG. Functional expression in HEK293 cells shows that a homotetrameric hERG channel reconstituted with only mutant subunits exhibits a drastically reduced surface expression of the channel protein thus leading to a diminished hERG current. Unlike many other mutations in the hERG-PAS domain the negative impact of the L69P substitution cannot be rescued by facilitated protein folding at a lower incubation temperature. Further, co-expression of wt and mutant monomers does not restore either wt like surface expression or the full hERG current. These results indicate L69P is a dominant negative mutation, with deficits which most likely occurs at the level of protein folding and subsequently inhibits trafficking to the plasma membrane. The functional deficits of the mutant channel support the clinical diagnosis of a LQTS.
No takes yet. Share an insight, caveat, or question.
Jenewein et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: